Your browser doesn't support javascript.
loading
Timing and Spectrum of Antibiotic Treatment for Suspected Sepsis and Septic Shock: Why so Controversial?
Pak, Theodore R; Rhee, Chanu; Klompas, Michael.
Affiliation
  • Pak TR; Division of Infectious Diseases, Massachusetts General Hospital, 55 Fruit Street, Cox Building, Suite #515, Boston, MA 02114, USA; Department of Population Medicine, Harvard Medical School/Harvard Pilgrim Health Care Institute, 401 Park Drive, Suite 401 East, Boston, MA 02215, USA.
  • Rhee C; Department of Population Medicine, Harvard Medical School/Harvard Pilgrim Health Care Institute, 401 Park Drive, Suite 401 East, Boston, MA 02215, USA; Division of Infectious Diseases, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA.
  • Klompas M; Department of Population Medicine, Harvard Medical School/Harvard Pilgrim Health Care Institute, 401 Park Drive, Suite 401 East, Boston, MA 02215, USA; Division of Infectious Diseases, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA. Electronic address: mklompas@bwh.harvard.edu.
Infect Dis Clin North Am ; 36(4): 719-733, 2022 12.
Article in En | MEDLINE | ID: mdl-36328632
Sepsis guidelines and mandates encourage increasingly aggressive time-to-antibiotic targets for broad-spectrum antimicrobials for suspected sepsis and septic shock. This has caused considerable controversy due to weaknesses in the underlying evidence and fear that overly strict antibiotic deadlines may harm patients by perpetuating or escalating overtreatment. Indeed, a third or more of patients currently treated for sepsis and septic shock have noninfectious or nonbacterial conditions. These patients risk all the potential harms of antibiotics without their possible benefits. Updated Surviving Sepsis Campaign guidelines now emphasize the importance of tailoring antibiotics to each patient's likelihood of infection, risk for drug-resistant pathogens, and severity-of-illness.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Shock, Septic / Sepsis Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Infect Dis Clin North Am Journal subject: DOENCAS TRANSMISSIVEIS Year: 2022 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Shock, Septic / Sepsis Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Infect Dis Clin North Am Journal subject: DOENCAS TRANSMISSIVEIS Year: 2022 Document type: Article Affiliation country: Country of publication: